Iovance Biotherapeutics
Biotechnology Research • 
San Carlos, California, United States • 501-1000 Employees
Company overview
| Headquarters | 825 Industrial Rd, Suite 400, San Carlos, California 94070, US |
| Phone number | +16502607120 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Cell Therapy, Immuno Oncology, Autologous Cell Therapy, Tumor Infiltrating Lymphocytes (Til), Novel Cancer Immunotherapies |
| Founded | 2007 |
| Employees | 501-1000 |
| Socials |
Key Contacts at Iovance Biotherapeutics
Martijn Bijker
Global Executive Director Medical Affairs Ex-Us Til Therapy
Brian Simpson
Senior Director Of Clinical Operations
Elizabeth Gonzalez
Human Resources Director
Kevin Shiau
Associate Director, Medical Communications
Amit Joshi
Senior Director Supply Chain
Elana Greenfield
Director, Technical Learning And Knowledge Management
Jim Hsiao
Director Cmc Technical Product Lead
Parinaz R.
Senior Director, Quality Operations
Paul Arquette
Tax Director
John Fisher
Regional Account Director
Iovance Biotherapeutics Email Formats
Iovance Biotherapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@iovance.com), used 88.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@iovance.com | 88.5% |
{first initial}.{last name} | j.doe@iovance.com | 10.7% |
About Iovance Biotherapeutics
Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. We are adding to our talented team as we execute our commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida. Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings
Iovance Biotherapeutics revenue & valuation
| Annual revenue | $241,600,000 |
| Revenue per employee | $259,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $772,900,000 |
| Total funding | $361,000,000 |
Employees by Management Level
Total employees: 501-1000
Seniority
Employees
Employees by Department
Iovance Biotherapeutics has 527 employees across 17 departments.
Departments
Number of employees
Funding Data
Explore Iovance Biotherapeutics's funding history, including investment rounds, total capital raised, and key backers.
Iovance Biotherapeutics Tech Stack
Discover the technologies and tools that power Iovance Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
CRM
PaaS
JavaScript libraries
Tag managers
Webmail
Miscellaneous
Miscellaneous
Video players
CDN
UI frameworks
Cookie compliance
Saudi Arabia
China
Switzerland
Germany
Italy
Finland
AustraliaFrequently asked questions
4.8
40,000 users
